VD

Vijaykumar Datla

Active Director Director DIN 00321796
DIN 00321796 First appointment Mar 1975 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 17 historical roles
Total affiliations 18 Since Mar 1975
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 29 Mar 1975
Active appointments 3
Total timeline records 18

Vijaykumar Datla (DIN 00321796) has 18 recorded board appointments in Indian companies, the first from March 1975, of which 3 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1975
Be Pharma Pvt Ltd Director · 1992 – present
Current
Eureka Laboratories Private Limited Director · 1991 – present
Current
V.R.Farms Private Limited Director · 1991 – present
Current
Be Vaccines Private Limited Director · 2012 – 2013
Previous
Biological E. Limited Managing Director · 2011 – 2013
Previous
Unnati Speciality Papers Private Limited Additional Director · 2008 – 2011
Previous
Previous
V.R.Construction Pvt Ltd Director · 2005 – 2013
Previous
V.R. Transport Co Pvt Ltd Director · 2005 – 2013
Previous
Previous
Biotech Medicals Private Limited Director · 1999 – 2013
Previous
B E Immuno Sciences Private Limited Director · 1999 – 2013
Previous
Be Animal Health Private Limited Director · 1998 – 2013
Previous
Biotech Pharma Pvt Ltd Director · 1989 – 2013
Previous
B.E. Investment And Finance Pvt Ltd Director · 1987 – 2013
Previous
Be Research Centre Director · 1985 – 2013
Previous
Previous
Veer Chemie And Aromatics Pvt Ltd Director · 1975 – 2013
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available